Detailed report at: http://www.reportsandintelligence.com/noninvasive-cancer-diagnostics-market Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. Inquire for sample request at: http://www.reportsandintelligence.com/purchase-enquiry/21952 According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. Web link: http://www.reportsandintelligence.com/

1. Noninvasive Cancer
Diagnostics and Technologies
Market
Global Share, Industry Overview,
Analysis, Growth, Trends Opportunities
and Forecast 2012 - 2020
Reports and Intelligence

2. Description
Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in
body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in
2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer
diagnostics is gaining importance over conventional diagnosis due to increase in incidences of
chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there
were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer
diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous
diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines
and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic
market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are
issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).
The global non-invasive market has a huge potential in developing countries; however, cost of
diagnosis is creating hurdles to tap this market. Hence, to overcome this problem, the diagnostic
market has to be analyzed by the developing countries such as China, Japan, and India.

3. Key Benefits
 Key developmental strategies adopted by top market players engaged in this business so that
companies involved in development non-invasive cancer diagnostic device can get competitive
intelligence of their competitors
 Market estimation for therapeutics techniques and geographic segment is derived from current
market scenario and expected market trends
 Market attractiveness analysis has been included for various product segments, therapeutics,
techniques and geographic regions with detailed analysis of factors responsible for rapid growth of
the market segments
 In depth analysis of key market drivers, restraints and opportunities of non-invasive cancer
diagnostic market with impact analysis
 Value chain analysis, Porter’s five force model, top investment pockets (GE9 Cell Matrix) are
analyzed and presented in detail in the report so that the decision makers can receive clear picture
of cancer diagnosis market

4. Key Market Segments
THERAPEUTICS
Solid tumors
Blood cancer
Lung Cancer
Breast Cancer
TECHNIQUES
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Other Clinical Instruments

5. Global Market By Geography

6. Get access to detailed
information at :
http://www.reportsandintelligence.com/noninvasive-cancer-diagnostics-market
http://www.reportsandintelligence.com/purchase-enquiry/21952